Keros Therapeutics, Inc. (NASDAQ:KROS) Short Interest Down 24.9% in March
Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totaling 1,494,814 shares, a...